Karbach et al. (24) found that gut microbiota may contribute to the development of hypertension in vivo by promoting angiotensin II (Ang-II) induced monocyte chemoattractant protein 1 (MCP-1)/IL-17-driven vascular immune cell infiltration and inflammation. This evidence concerns the gene AGT and Hypertension.